Sanofi announced that at the AGM was held on April 30, 2024, the company approved the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy, all being qualified as independent Directors. On the proposal of the Appointments, Governance and CSR Committee, the Board of Directors has appointed Clotilde Delbos as member of the Audit and Compensation Committees, Anne-Françoise Nesmes as member of the Audit Committee and John Sundy as member of the Scientific Committee. Antoine Yver becomes Chair of the Scientific Committee and a member of the Strategy Review Committee.